Tanya Samazan[email protected]Trends and FinancePCR-based life science tools top $5B, with digital PCR showing rapid growth: SDi reportAmong the PCR technologies for the life sciences laboratory tools industry, dPCR is the fastest growing, as evidenced by the recent market entry of large qPCR vendors.December 6, 2022InfectiousCOVID-19-related sales remain strong for lab tool firms in 2021Thermo Fisher ScientificDecember 8, 2021Page 1 of 1Top StoriesFDA ClearancePillar Biosciences gets FDA approval for NGS solid tumor profiling testPillar Biosciences has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its OncoReveal CDx pan-cancer next-generation sequencing (NGS) test for general solid tumor profiling.ValidationImmunovia announces positive results for next-gen pancreatic cancer testCollaborationVertex to pay $25M upfront to scale cell manufacturing technologyFinancial ResultsBristol Myers Squibb to reduce workforce in restructuring planSponsor ContentVisit our Molecular Diagnostics Community